Table 3.
Association of Topo–IIα Amplification With Disease and Treatment Variables
Variable | Topo–IIα Amplified | Topo–IIα Deleted | Topo–IIα Normal | P |
---|---|---|---|---|
HER2 IHC 3+, No. of cases | 90 | 50 | 1.0 | < .0001 |
FISH, ratio | 4.5 | 1.11 | 1.05 | < .0001 |
S phase, % nuclei | 17.5 | 14 | 12 | .12 |
ER, % nuclei | 55 | 61 | 67 | .20 |
NOTE. The values displayed for HER2 IHC, FISH ratio, and S phase are medians and for ER the percentage positive. Differences in the mean ranks or proportions are compared using the Kruskal–Wallis test.
Abbreviations: Topo–IIα, topoisomerase IIα; IHC, immunohistochemistry; FISH, fluorescence in situ hybridization; ER, estrogen receptor.